PIPERACILLIN TAZOBACTAM (YTR-830) COMBINATION - COMPARATIVE ANTIMICROBIAL ACTIVITY AGAINST 5889 RECENT AEROBIC CLINICAL ISOLATES AND 60 BACTEROIDES-FRAGILIS GROUP STRAINS

被引：59

作者：

JONES, RN

PFALLER, MA

FUCHS, PC

ALDRIDGE, K

ALLEN, SD

GERLACH, EH

机构：

[1] CLIN MICROBIOL INST INC,TUALATIN,OR

[2] ST VINCENT HOSP & MED CTR,PORTLAND,OR

[3] INDIANA UNIV,MED CTR,INDIANAPOLIS,IN 46204

[4] UNIV IOWA,MED CTR,IOWA CITY,IA 52242

[5] LOUISIANA STATE UNIV,MED CTR,NEW ORLEANS,LA 70112

[6] ST FRANCIS REG MED CTR,WICHITA,KS 67214

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1989年 / 12卷 / 06期

关键词：

D O I：

10.1016/0732-8893(89)90083-7

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：489 / 494

页数：6

共 17 条

[1] COMPARATIVE ACTIVITY OF BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH BETA-LACTAMS AGAINST BETA-LACTAMASE-PRODUCING ANAEROBES
APPELBAUM, PC
JACOBS, MR
SPANGLER, SK
YAMABE, S
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) : 789 - 791
[2] SYNERGY OF AMOXICILLIN COMBINED WITH CLAVULANATE AND YTR 830 IN EXPERIMENTAL INFECTIONS IN MICE
ARONOFF, SC
JACOBS, MR
LABROZZI, PH
YAMABE, S
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (02) : 271 - 276
[3] COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR-830, SODIUM CLAVULANATE, AND SULBACTAM COMBINED WITH AMOXICILLIN OR AMPICILLIN
ARONOFF, SC
JACOBS, MR
JOHENNING, S
YAMABE, S
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) : 580 - 582
[4] BETA-LACTAMASE INHIBITORS IN PERSPECTIVE
BUSH, K
SYKES, RB
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (02) : 97 - 107
[5] CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION
ENGLISH, AR
RETSEMA, JA
GIRARD, AE
LYNCH, JE
BARTH, WE
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) : 414 - 419
[6] INVITRO ACTIVITY AND DISK SUSCEPTIBILITY OF TIMENTIN - CURRENT STATUS
FUCHS, PC
BARRY, AL
JONES, RN
[J]. AMERICAN JOURNAL OF MEDICINE, 1985, 79 (5B) : 25 - 32
[7] COMPARATIVE-EVALUATION OF A NEW BETA-LACTAMASE INHIBITOR, YTR 830, COMBINED WITH DIFFERENT BETA-LACTAM ANTIBIOTICS AGAINST BACTERIA HARBORING KNOWN BETA-LACTAMASES
GUTMANN, L
KITZIS, MD
YAMABE, S
ACAR, JF
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (05) : 955 - 957
[8] COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE AND SULBACTAM COMBINED WITH EXTENDED-SPECTRUM PENICILLINS AGAINST TICARCILLIN-RESISTANT ENTEROBACTERIACEAE AND PSEUDOMONADS
JACOBS, MR
ARONOFF, SC
JOHENNING, S
YAMABE, S
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (02) : 177 - 184
[9] COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH AMPICILLIN AND BROAD-SPECTRUM PENICILLINS AGAINST DEFINED BETA-LACTAMASE-PRODUCING AEROBIC GRAM-NEGATIVE BACILLI
JACOBS, MR
ARONOFF, SC
JOHENNING, S
SHLAES, DM
YAMABE, S
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) : 980 - 985
[10] CEFTAZIDIME, A PSEUDOMONAS-ACTIVE CEPHALOSPORIN - INVITRO ANTIMICROBIAL ACTIVITY EVALUATION INCLUDING RECOMMENDATIONS FOR DISK DIFFUSION SUSCEPTIBILITY TESTS
JONES, RN
BARRY, AL
THORNSBERRY, C
GERLACH, EH
FUCHS, PC
GAVAN, TL
SOMMERS, HM
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 : 187 - 211

← 1 2 →